systems biology | GenomeWeb

systems biology

The agency has committed $11 million for the creation of a network of research centers that will use systems biology approaches to build predictive models for infectious diseases.

Called CanPathPro, the research consortium aims to combine omics data and systems biology tools into a single commercial platform for testing cancer hypotheses.

The consortium was launched last year as a network of research centers focused on building predictive models of cancer initiation, progression, and metastasis.

The new challenge focuses on computational methods for identifying blood gene expression signatures that can be used as markers of smoking exposure.

Up to five new grants will take a systems biology and omics approach to research the molecular interactions between pathogens and hosts.

NEW YORK (GenomeWeb) – Swiss contract research firm Intomics said today that it has inked an agreement to collaborate with Actelion Pharmaceuticals on research into neurodegenerative diseases.

NEW YORK (GenomeWeb) – Bioinformatics firm Berg today said that it will collaborate with researchers at the University of South Carolina in a search for lupus biomarkers.

NEW YORK (GenomeWeb News) – A pilot opportunity was launched on Tuesday by US and UK funding agencies to simplify the funding application process for researchers in the two countries who wish to collaborate on projects.

As researchers increasingly rely on sequencing to tally up variation within and between populations, the technology is poised to contribute to future functional studies of human adaptations and more.

NEW YORK (GenomeWeb News) – Three US research teams have reeled in $4.9 million in funding from the National Institutes of Health to use genomics and systems biology approaches to delve into the molecular basis of Alzheimer's disease.

Pages

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.